{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:44:37Z","timestamp":1778154277576,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.rdc.2022.02.009","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T18:33:11Z","timestamp":1649356391000},"page":"523-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome"],"prefix":"10.1016","volume":"48","author":[{"given":"Adela","family":"Castro-Gutierrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie L.","family":"Bermas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rdc.2022.02.009_bib1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/art.30327","article-title":"Time to pregnancy among women with rheumatoid arthritis","volume":"63","author":"Jawaheer","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2022.02.009_bib2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/acr.23124","article-title":"Subfertility in Women With Rheumatoid Arthritis and the Outcome of Fertility Assessments","volume":"69","author":"Brouwer","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/BOR.0000000000000058","article-title":"Fertility and infertility in rheumatoid arthritis","volume":"26","author":"Provost","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2022.02.009_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3899\/jrheum.180176","article-title":"Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis","volume":"46","author":"Eudy","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.02.009_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbspin.2009.11.009","article-title":"The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity","volume":"77","author":"Zrour","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.rdc.2022.02.009_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41584-019-0351-2","article-title":"Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity","volume":"16","author":"F\u00f6rger","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2022.02.009_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/art.24003","article-title":"Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study","volume":"59","author":"de Man","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2022.02.009_bib8","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2012.13644","article-title":"Pregnancy mediated improvement of rheumatoid arthritis","author":"F\u00f6rger","year":"2012","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"10.1016\/j.rdc.2022.02.009_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13075-017-1269-1","article-title":"Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients","volume":"19","author":"van den Brandt","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.rdc.2022.02.009_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semarthrit.2019.03.011","article-title":"Obstetric outcomes in women with rheumatoid arthritis: Results from Nationwide Inpatient Sample Database 2003\u20132011\u2730","volume":"49","author":"Kishore","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2022.02.009_bib11","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: Results of a national prospective study","volume":"60","author":"de Man","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2022.02.009_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/03009740902763099","article-title":"Reproductive health in women with systemic lupus erythematosus compared to population controls","volume":"38","author":"Ekblom-Kullberg","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2022.02.009_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.55.4.224","article-title":"Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide","volume":"55","author":"McDermott","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2022.02.009_bib14","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/rheumatology\/ker105","article-title":"Causes and management of infertility in systemic lupus erythematosus","volume":"50","author":"Hickman","year":"2011","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0961203317726378","article-title":"Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age","volume":"27","author":"Gao","year":"2018","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.rdc.2022.02.009_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12020-018-1783-1","article-title":"Anti-M\u00fcllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve","volume":"63","author":"Di Mario","year":"2019","journal-title":"Endocrine"},{"issue":"12","key":"10.1016\/j.rdc.2022.02.009_bib17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1177\/0961203315586455","article-title":"Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancy","volume":"24","author":"Tedeschi","year":"2015","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.21663","article-title":"Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"Chakravarty","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/M19-0120","article-title":"Trends in Maternal and Fetal Outcomes Among Pregnant Women With Systemic Lupus Erythematosus in the United States","volume":"171","author":"Mehta","year":"2019","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of Pregnancy Outcomes in Patients With Lupus","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.rdc.2022.02.009_bib21","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2022.02.009_bib22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0961203317749046","article-title":"Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015","volume":"27","author":"Bermas","year":"2018","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.rdc.2022.02.009_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"MIYAKIS","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.rdc.2022.02.009_bib24","doi-asserted-by":"crossref","first-page":"e000131","DOI":"10.1136\/lupus-2015-000131","article-title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results","volume":"3","author":"Yelnik","year":"2016","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.rdc.2022.02.009_bib25","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3389\/fimmu.2019.01948","article-title":"Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies","volume":"10","author":"Lazzaroni","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2022.02.009_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1515\/cclm-2017-0502","article-title":"Antiphosphatidylserine\/prothrombin antibodies (aPS\/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome","volume":"56","author":"Shi","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.rdc.2022.02.009_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ogc.2013.10.004","article-title":"Antiphospholipid Antibody Syndrome","volume":"41","author":"Kutteh","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"10","key":"10.1016\/j.rdc.2022.02.009_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11926-018-0772-y","article-title":"Obstetric Anti-phospholipid Syndrome: State of the Art","volume":"20","author":"Gerardi","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"suppl_5","key":"10.1016\/j.rdc.2022.02.009_bib29","doi-asserted-by":"crossref","first-page":"v2","DOI":"10.1093\/rheumatology\/key010","article-title":"The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy","volume":"57","author":"Bermas","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.rdc.2022.02.009_bib30","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/rheumatology\/kev405","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding\u2014Part II: analgesics and other drugs used in rheumatology practice: Table\u00a01","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.rdc.2022.02.009_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2022.02.009_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib33","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1542\/peds.2011-3552","article-title":"Breastfeeding and the use of human milk","volume":"129","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.rdc.2022.02.009_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.reprotox.2007.11.010","article-title":"Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis","volume":"25","author":"Rahimi","year":"2008","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.rdc.2022.02.009_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/j.1536-4801.1986.tb09071.x","article-title":"Bloody diarrhea--a possible complication of sulfasalazine transferred through human breast milk","volume":"5","author":"Branski","year":"1986","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.rdc.2022.02.009_bib36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/bdra.20399","article-title":"Pregnancy outcome of women exposed to azathioprine during pregnancy","volume":"79","author":"Goldstein","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"7","key":"10.1016\/j.rdc.2022.02.009_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/00016349409006270","article-title":"Pregnancy outcome in renal allograft recipients in Norway. The importance of immunosuppressive drug regimen and health status before pregnancy","volume":"73","author":"Haugen","year":"1994","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.rdc.2022.02.009_bib38","first-page":"1089","article-title":"Outcomes of 500 pregnancies in 335 female kidney, liver, and heart transplant recipients","volume":"27","author":"Radomski","year":"1995","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.rdc.2022.02.009_bib39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar Oz","year":"2001","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.rdc.2022.02.009_bib40","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/00007890-200012270-00010","article-title":"Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus","volume":"70","author":"Kainz","year":"2000","journal-title":"Transplantation"},{"issue":"7974","key":"10.1016\/j.rdc.2022.02.009_bib41","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","article-title":"Aspirin and congenital malformations","volume":"1","author":"Slone","year":"1976","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2022.02.009_bib42","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1177\/096120339800700221","article-title":"Treatment of antiphospholipid syndrome in pregnancy","volume":"7","author":"Cowchock","year":"1998","journal-title":"Lupus"},{"issue":"9575","key":"10.1016\/j.rdc.2022.02.009_bib43","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0002-9378(77)90466-5","article-title":"In\u00a0vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta","volume":"127","author":"Blanford","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.rdc.2022.02.009_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"issue":"7","key":"10.1016\/j.rdc.2022.02.009_bib46","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"issue":"3\u20134","key":"10.1016\/j.rdc.2022.02.009_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0897.1992.tb00777.x","article-title":"NSAIDs: maternal and fetal considerations","volume":"28","author":"Schoenfeld","year":"1992","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2022.02.009_bib48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1345\/aph.1G428","article-title":"Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis","volume":"40","author":"Koren","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"15","key":"10.1016\/j.rdc.2022.02.009_bib49","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.rdc.2022.02.009_bib50","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1503\/cmaj.130605","article-title":"Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions","volume":"186","author":"Daniel","year":"2014","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","article-title":"A\u00a0safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database","volume":"36","author":"Carter","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2022.02.009_bib52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bcp.12642","article-title":"Pregnancy outcome after TNF-\u03b1 inhibitor therapy during the first trimester: a prospective multicentre cohort study","volume":"80","author":"Weber-Schoendorfer","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/1744666X.2019.1561282","article-title":"From mother to baby: antenatal exposure to monoclonal antibody biologics","volume":"15","author":"Pham-Huy","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"12","key":"10.1016\/j.rdc.2022.02.009_bib54","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3899\/jrheum.140189","article-title":"Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol","volume":"42","author":"Clowse","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.02.009_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000030","article-title":"Systemic lupus erythematosus and pregnancy outcomes","volume":"26","author":"Peart","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2022.02.009_bib56","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.rdc.2022.02.009_bib57","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/ard.2004.030254","article-title":"Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome","volume":"64","author":"De Santis","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2022.02.009_bib58","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/art.34419","article-title":"Pregnancy outcome in women exposed to leflunomide before or during pregnancy","volume":"64","author":"Cassina","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2022.02.009_bib59","first-page":"51","article-title":"Single-dose systemic methotrexate for the treatment of persistent ectopic pregnancy after conservative surgery","volume":"83","author":"Hoppe","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.rdc.2022.02.009_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9","article-title":"Adult and two children with fetal methotrexate syndrome","volume":"57","author":"Bawle","year":"1998","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.rdc.2022.02.009_bib61","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajmg.a.35223","article-title":"Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services","volume":"158A","author":"Hoeltzenbein","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.rdc.2022.02.009_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-74-1-87","article-title":"Fetal effects during cyclophosphamide and irradiation therapy","volume":"74","author":"Toledo","year":"1971","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.rdc.2022.02.009_bib63","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1200\/JCO.2005.03.038","article-title":"Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching Hospitals","volume":"23","author":"Ring","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.rdc.2022.02.009_bib64","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/096120330101001110","article-title":"Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy","volume":"10","author":"K\u00f6zdemir","year":"2001","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.rdc.2022.02.009_bib65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40264-016-0431-z","article-title":"Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis","volume":"39","author":"Clowse","year":"2016","journal-title":"Drug Saf"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X22000096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X22000096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:29:51Z","timestamp":1760182191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X22000096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0889857X22000096"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2022.02.009","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2022.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}